Navigation Links
Irving Dark Named Vice President of Cytel Clinical Research Services
Date:1/16/2008

Proven Executive Brings Both Clinical Trial Experience and Business

Development Leadership to Clinical Trial Services Management Role

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Cytel, Inc. announced today that clinical research and business development executive Irving Dark has accepted the role of Vice President of Cytel Clinical Research Services. Mr. Dark brings to Cytel 15-years of management experience guiding drug, biologic and medical device products successfully through the development process as well as growing commercial clinical research organizations.

In his new position, Mr. Dark will head and drive the growth of Cytel's cutting-edge clinical trial design and implementation services to the biopharmaceutical industry.

Prior to joining Cytel, Mr. Dark was Vice President, Business Development and Operations for Veristat, Inc. During his tenure he established and oversaw the company's Data Management, Project Management, and Business Development departments. Mr. Dark was integrally involved with Veristat's Corporate Compliance activities to ensure adherence with regulatory and GCP guidelines, and was instrumental in the company's oncology and influenza contracts, and the Acambis smallpox vaccine program.

Previously, Mr. Dark held several key positions at full-service trial leader PAREXEL, rising from statistical programming management to overseeing the planning and conduct of phase 1, 2, and 3 global clinical trials.

"Irving's experience in trial management and his knowledge of the clinical development needs of the biopharmaceutical industry are ideally suited to growing Cytel's innovative clinical research services" said Ranganath Nayak, Chief Executive Officer of Cytel.

"Cytel has an impressive track record delivering innovative solutions to the biopharmaceutical industry," said Irving Dark. "Cytel's experience designing innovative clinical trials and its advanced analytical capabilities differentiate
'/>"/>

SOURCE Cytel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Panacea Pharmaceuticals Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazines Ten Biggest Medical Breakthroughs of 2007
2. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
3. Kent Riddle Named To Piedmont Triad Biotechnology Development Group
4. Deloitte Chairman of the Board Sharon L. Allen Named Chairman of the American Friends of the Phelophepa Train
5. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
6. K-States Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science
7. Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry
8. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
9. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
10. DuPont Named Among Top Biotechnology Employers by Science Magazine
11. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...ronmental,Technologies, Inc. (OTC Bulletin Board: ...nce of its comprehensive livestock environmental,t...s., Anaerobic or methane digestion (AD) has been ...the late 1800s. While its efficiency has,improved ...process that,produces biogas (which generally cont...
...itories Event for the Pharmaceutical and ..., June 23 BioStorage Technologies, Inc., a,provid...e, sample,management and cold chain logistics, ann... for International Research,s (IIR) inaugural,Bior...e pharmaceutical and,biotech industries. Taking pl...
...y Commission funds formulation of two beverages wi...nologies., TORONTO, June 23 /PRNewswire-FirstCall...ormulation of two dairy beverages with GG-XT for A...e filed Canadian and International Patent Applicat...ns for GG-XT. GG-XT is a,proprietary compound of P...
Other Biology Technology:Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 2Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 3Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 4Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 5Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 6Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 7BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008 2Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 2Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 3
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 1HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 3Sofinnova Partners Leads Investment Round in CoAxia 49695 1Sofinnova Partners Leads Investment Round in CoAxia 49695 2Sofinnova Partners Leads Investment Round in CoAxia 49695 3CoAxia Inc Announces 2421 5M Series D Financing 4628 1CoAxia Inc Announces 2421 5M Series D Financing 4628 2CoAxia Inc Announces 2421 5M Series D Financing 4628 3
...ings, will she end up demented? These days, memory...nal which 70-year-olds risk developing dementia. T...ka Academy at the University of Gothenburg, Sweden...ct which elderly individuals risk developing demen...ws that memory loss is the only factor that can st...
...ity Belfast have discovered a new eco-friendly way...elp its transformation into popular products such ...ctor Rodrguez and Professor Robin Rogers from the ...neering worked along with The University of Alabam... energy efficient way of processing wood. , Thei...
...owth of institutional Memberships for open access ...announces the introduction of the "Online Reportin...embership accounts. Building on BioMed Central,s c... system will assist organizations, annual publicat...osts associated with managing open access publicat...
Other Biology News:Early identification of dementia increasingly difficult 2Queen's scientists discover eco-friendly wood dissolution 2
Rabbit Anti-ACAT-1 (H-125) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...ide-1(7-36) amide (GLP-1), C-terminal reactive. Cr...<0.1% cross reactivity with the unamidated forms G...es such as hGLP-2, glucagon, hGIP and VIP.,SPECI...identical in all mammalian species studied except ...
Anti-Lineage 1 (lin 1) Cocktail Monoclonal Antibody, FITC Conjugated from BD Biosciences - Immunocytometry Systems
Goat Anti-BAI-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: